INFUSYSTEM HOLDINGS INC (INFU) Stock Price, Forecast & Analysis

NYSEARCA:INFU • US45685K1025

8.77 USD
-0.42 (-4.57%)
At close: Feb 27, 2026
8.77 USD
0 (0%)
After Hours: 2/27/2026, 8:11:15 PM

INFU Key Statistics, Chart & Performance

Key Statistics
Market Cap178.38M
Revenue(TTM)N/A
Net Income(TTM)5.52M
Shares20.34M
Float18.90M
52 Week High11.04
52 Week Low4.61
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.32
PE27.41
Fwd PE20.91
Earnings (Next)05-06
IPO2006-06-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
INFU short term performance overview.The bars show the price performance of INFU in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10

INFU long term performance overview.The bars show the price performance of INFU in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5

The current stock price of INFU is 8.77 USD. In the past month the price increased by 8.94%. In the past year, price increased by 9.9%.

INFUSYSTEM HOLDINGS INC / INFU Daily stock chart

INFU Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to INFU. When comparing the yearly performance of all stocks, INFU turns out to be only a medium performer in the overall market: it outperformed 46.85% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
INFU Full Technical Analysis Report

INFU Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to INFU. INFU has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
INFU Full Fundamental Analysis Report

INFU Financial Highlights

Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.32. The EPS increased by 220% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.92%
ROA 5.59%
ROE 9.96%
Debt/Equity 0.38
Chartmill High Growth Momentum
EPS Q2Q%150%
Sales Q2Q%7.04%
EPS 1Y (TTM)220%
Revenue 1Y (TTM)N/A
INFU financials

INFU Forecast & Estimates

11 analysts have analysed INFU and the average price target is 14.48 USD. This implies a price increase of 65.15% is expected in the next year compared to the current price of 8.77.

For the next year, analysts expect an EPS growth of 31.07% and a revenue growth 2.9% for INFU


Analysts
Analysts83.64
Price Target14.48 (65.11%)
EPS Next Y31.07%
Revenue Next Year2.9%
INFU Analyst EstimatesINFU Analyst Ratings

INFU Ownership

Ownership
Inst Owners75.72%
Ins Owners4.8%
Short Float %0.63%
Short Ratio0.9
INFU Ownership

INFU Latest News, Press Relases and Analysis

All INFU news

INFU Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP11.0399.028B
CI THE CIGNA GROUP9.2776.092B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27100.7224.114B
LH LABCORP HOLDINGS INC16.0523.844B
DGX QUEST DIAGNOSTICS INC20.1623.483B
GH GUARDANT HEALTH INC N/A12.622B
DVA DAVITA INC11.8210.457B
BTSG BRIGHTSPRING HEALTH SERVICES30.247.237B
CHE CHEMED CORP15.985.616B
RDNT RADNET INC87.755.579B

About INFU

Company Profile

INFU logo image InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

Company Info

INFUSYSTEM HOLDINGS INC

3851 West Hamlin Road

Rochester Hills MICHIGAN 48309 US

CEO: Richard DiIorio

Employees: 502

INFU Company Website

INFU Investor Relations

Phone: 12482911210

INFUSYSTEM HOLDINGS INC / INFU FAQ

Can you describe the business of INFUSYSTEM HOLDINGS INC?

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.


What is the current price of INFU stock?

The current stock price of INFU is 8.77 USD. The price decreased by -4.57% in the last trading session.


Does INFU stock pay dividends?

INFU does not pay a dividend.


How is the ChartMill rating for INFUSYSTEM HOLDINGS INC?

INFU has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is INFUSYSTEM HOLDINGS INC (INFU) stock traded?

INFU stock is listed on the NYSE Arca exchange.


Can you provide the PE ratio for INFU stock?

The PE ratio for INFUSYSTEM HOLDINGS INC (INFU) is 27.41. This is based on the reported non-GAAP earnings per share of 0.32 and the current share price of 8.77 USD.


What is INFUSYSTEM HOLDINGS INC worth?

INFUSYSTEM HOLDINGS INC (INFU) has a market capitalization of 178.38M USD. This makes INFU a Micro Cap stock.